{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-182569","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.784822+00:00","generated_at":"2026-05-31T18:19:19.433733+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Owens & Minor to buy Rotech for $1.36B cash; expects ~$0.15 EPS accretion in second year","bullets":["Purchase price $1.36B cash; net $1.32B after ~$40M tax benefits; ~6.3x LTM EBITDA ex-synergies.","Rotech 2023 revenue ~$750M with ~30% EBITDA margin; 4,200+ employees, ~325 locations in 46 states.","Expected close by end of 2024; subject to HSR; financed with $775M term loan B and $625M bridge.","Synergies ~$50M by end of year three; adjusted EPS neutral in first full year, accretive in second year.","Owens & Minor reaffirms 2024 full-year guidance; preliminary Q2 results reported separately."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-182569","json":"https://secwatch.observer/filing/0001193125-24-182569.json","markdown":"https://secwatch.observer/filing/0001193125-24-182569.md","text":"https://secwatch.observer/filing/0001193125-24-182569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/0001193125-24-182569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/d861390d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:19:19.433733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}